Steward Partners Investment Advisory’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1
| Closed | -$3 | – | 3847 |
|
|
2024
Q2 | $3 | Hold |
1
| – | – | ﹤0.01% | 3603 |
|
|
2024
Q1 | $7 | Hold |
1
| – | – | ﹤0.01% | 3554 |
|
|
2023
Q4 | $6 | Hold |
1
| – | – | ﹤0.01% | 3483 |
|
|
2023
Q3 | $8 | Hold |
1
| – | – | ﹤0.01% | 3370 |
|
|
2023
Q2 | $14 | Hold |
1
| – | – | ﹤0.01% | 3307 |
|
|
2023
Q1 | $10 | Hold |
1
| – | – | ﹤0.01% | 3295 |
|
|
2022
Q4 | $6 | Hold |
1
| – | – | ﹤0.01% | 3347 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 3381 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 3371 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 3380 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 3320 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 3334 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7392 |
|
|
2021
Q1 | $98 | Hold |
1
| – | – | ﹤0.01% | 3387 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2992 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2850 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2751 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2700 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2745 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2769 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2694 |
|
|
2018
Q4 | – | Sell |
-1
| Closed | – | – | 2041 |
|
|
2018
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2704 |
|
|
2018
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 2397 |
|
|
2018
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 2164 |
|
|
2017
Q4 | $2K | Hold |
1
| – | – | ﹤0.01% | 1724 |
|
|
2017
Q3 | $4K | Hold |
1
| – | – | ﹤0.01% | 1367 |
|
|
2017
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 1445 |
|
|
2017
Q1 | $3K | Buy |
+1
| New | +$3K | ﹤0.01% | 1261 |
|